Patent · US Active

Anti-FAP antibodies and methods of use

US11332545B2 · kind B2 · utility

4Cited by

9References

9Claims

0Family size

Assignee

Roche Glycart AG · CH

Inventors

Marina BACAC · Schlieren, CH
Anne Freimoser-Grundschober · Bellinzona, CH
Ralf Hosse · Baar, CH
Christian Klein · Iffeldorf, DE
Ekkehard Moessner · Kreuzlingen, CH
Valeria G. Nicolini · Küsnacht (ZH), CH
Pablo Umana · Wollerau, CH

Key dates

Filing date	Apr 8, 2019
Grant date	May 17, 2022
Priority date	—
Expiry date	Mar 12, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides antibodies against Fibroblast Activation Protein (FAP) and methods of using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.